September 1, 2015 / 6:36 AM / 2 years ago

BRIEF-Zeltia says pharmaceutical council recommends approval of Yondelis in Japan

Sept 1 (Reuters) - Zeltia SA :

* Says the Japanese Pharmaceutical Affairs and Food Sanitation Council (PAFSC) has recommended approval of Yondelis (trabectedin) in Japan

* The recommendation is for Yondelis to treat patients with soft tissue sarcoma in Japan

* Based on the review report prepared by the Japanese regulatory agency (PMDA) for Yondelis, the PAFCS has provided a positive opinion to the Japanese Ministry of Health, Labour and Welfare (MHLW), which will then issue the marketing authorization Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below